Table 4.
Percentage of respondents voting “yes” for each of the consensus indicators.
| Domain | PRO measure | Percentage of respondents voting “yes” |
||
|---|---|---|---|---|
| Relevance | Comprehensiveness | Ease of understanding | ||
| Symptom Burden | FACT (BMT) | 58% | 53% | 79% |
| MDASI-CAR | 68% | 63% | 68% | |
| QoL-BMT | 63% | 63% | 47% | |
| SBQ | 79% | 79% | 74% | |
| Impacts of Disease and Treatment | FACT (BMT) | 63% | 74% | 84% |
| MyPOS | 37% | 53% | 84% | |
| QoL-BMT | 74% | 74% | 58% | |
| SCNC-SF34 | 63% | 68% | 68% | |
| QLACS | 74% | 74% | 84% | |
FACT (BMT), Functional Assessment of Cancer Therapy–Bone Marrow Transplant; MDASI-CAR, MD Anderson Symptom Inventory CAR module; QoL-BMT, Quality of Life Bone Marrow Transplant; SBQ, Symptom Burden Questionnaire; MYPOS, Myeloma Patient Outcome Scale; SCNS-SF34, Supportive Care Needs Survey—Short Form 34; QLACS, Quality of Life in Adult Cancer Survivors.